In summary, our approach yielded key insights into the roles of inflammatory niches and the CXCL12-CXCR4-PI3K/AKT/mTOR axis in AML progression, including the possibility that the endosteal niche supports more primitive AML populations. This evidence concerns the gene CXCL12 and acute myeloid leukemia.